Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Medtronic PLC (NYSE:MDT)

81.00
Delayed Data
As of Mar 24
 +0.14 / +0.17%
Today’s Change
69.35
Today|||52-Week Range
89.27
+13.72%
Year-to-Date
MDT Regular Dividend: MDT began trading ex-dividend on 03/22/17. A $0.43 dividend will be paid to shareholders of record as of 03/24/17.
Primecap Sells NVIDIA, Microsoft, Union Pacific
Mar 23 / GuruFocus News - Paid Partner Content
Medtronic's Positive 2-Year SURTAVI Data Boosts Corevalve
Mar 20 / Zacks.com - Paid Partner Content
Medtronic's (MDT) CoreValve Evolut Pro Receives FDA Approval
Mar 23 / Zacks.com - Paid Partner Content
Mazor Robotics-Medtronic's Mazor X Partnership Strengthens
Mar 20 / Zacks.com - Paid Partner Content
Intel Elects Two New Members to its Board
Mar 23 / TheStreet.com - Paid Partner Content
Dividend Aristocrats: Medtronic vs. Becton, Dickinson & Company
Mar 19 / GuruFocus News - Paid Partner Content
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Medtronic's Melody TPV Wins FDA for Less-Invasive Treatment
Mar 16 / Zacks.com - Paid Partner Content
Dodge & Cox Buys Bristol-Myers Squibb Company, Zayo Group Holdings, Medtronic PLC, Se...
Mar 20 / GuruFocus News - Paid Partner Content
Medtronic's New Reveal LINQ ICM Gets FDA 510(k) Clearance
Mar 15 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close80.86
Today’s open80.85
Day’s range80.85 - 81.47
Volume3,010,258
Average volume (3 months)6,157,785
Market cap$110.9B
Dividend yield2.12%
Data as of 4:02pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+2.90%
Earnings growth (this year)+4.77%
Earnings growth (next 5 years)+6.73%
Revenue growth (last year)+42.31%
P/E ratio28.6
Price/Sales3.91
Price/Book2.18

Competitors

 Today’s
change
Today’s
% change
RMDResMed Inc+0.26+0.36%
VARVarian Medical Syste...-0.16-0.18%
NVRONevro Corp+2.19+2.39%
LIVNLivaNova PLC+1.19+2.42%
Data as of 4:02pm ET, 03/24/2017

Financials

Next reporting dateMay 25, 2017
EPS forecast (this quarter)$1.31
Annual revenue (last year)$28.8B
Annual profit (last year)$3.5B
Net profit margin12.27%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Omar S. Ishrak
Chief Financial Officer &
Executive Vice President
Karen L. Parkhill
Corporate headquarters
Dublin, Dublin

Forecasts


Search for Jobs